GlassScriptPhysician profile
Holly M Gross
NPI 1164498598
$1,871.32
in general payments reported to CMS, 2019-2025
15 companies · $198 in 2025
The $198 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $531 · 2020: $72.59 · 2021: $66.39 · 2022: $425 · 2023: $399 · 2024: $179 · 2025: $198.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $776.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $775.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $528.05 | 2019-2025 | Hydrus Microstent, Argos, Tryptyr |
| Allergan, INC. | $277.02 | 2019-2022 | |
| New World Medical,INC. | $223.14 | 2022-2024 | Kahook Dual Blade, Streamline, Clearpath |
| Shire North American Group INC | $143.78 | 2019 | |
| Bausch & Lomb Americas INC. | $122.20 | 2023 | Miebo, Vyzulta |
| Integra Lifesciences Corporation | $118.89 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $108.52 | 2024 | Xdemvy |
| Sun Pharmaceutical Industries INC. | $89.45 | 2025 | |
| Rxsight INC | $83.19 | 2023 | Rxsight Light Adjustable Lens (Rxlal), Rxsight Injector Cartridge, Rxsight Injector Handpiece |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $73.08 | 2019 | |
| Oyster Point Pharma, INC. | $25.67 | 2024 | Ryzumvi |
| Johnson & Johnson Surgical Vision, INC. | $24.05 | 2019 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Horizon Therapeutics Plc | $17.64 | 2023 | Tepezza |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Holly Gross listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.